Golden State Equity Partners Mereo Biopharma Group PLC Transaction History
Golden State Equity Partners
- $402 Million
- Q4 2023
A detailed history of Golden State Equity Partners transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Golden State Equity Partners holds 20,300 shares of MREO stock, worth $78,764. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,300
Previous 14,400
40.97%
Holding current value
$78,764
Previous $18,000
155.56%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding MREO
# of Institutions
87Shares Held
85.6MCall Options Held
182KPut Options Held
249K-
Rubric Capital Management LP New York, NY13.6MShares$52.6 Million1.52% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.33MShares$36.2 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.75MShares$34 Million3.09% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD8.14MShares$31.6 Million0.7% of portfolio
-
683 Capital Management, LLC New York, NY5.75MShares$22.3 Million1.62% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $485M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...